BELATACEPTMeSH concept

https://ansm.sante.fr/tableau-marr/belatacept
2024
false
false
false
France
French
guidelines for drug use
risk management
BELATACEPT
immunosuppressive agents
infusions, intravenous
belatacept
patient education handout
Infusion-Related Reaction
infusions, intravenous

---
https://www.has-sante.fr/jcms/p_3456515/fr/nulojix-belatacept-prevention-du-rejet-de-greffon-renal
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug therapy, combination
adult
kidney transplantation
infusions, intravenous
belatacept
mycophenolic acid
glucocorticoids
evaluation of the transparency committee
BELATACEPT
Abatacept
graft rejection

---
https://www.has-sante.fr/jcms/p_3380392/fr/nulojix-belatacept-prevention-du-rejet-de-greffon-renal-adultes
2022
false
false
false
France
kidney transplantation
insurance, health, reimbursement
treatment outcome
infusions, intravenous
immunosuppressive agents
drug therapy, combination
glucocorticoids
mycophenolic acid
belatacept
Calcineurin Inhibitors
evaluation of the transparency committee
graft rejection
Abatacept
adult
BELATACEPT

---
http://www.has-sante.fr/portail/jcms/c_2723467/fr/nulojix
http://www.has-sante.fr/portail/jcms/c_2723467/fr/nulojix-belatacept-immunosuppresseur-selectif
2016
false
France
French
evaluation of the transparency committee
corticosteroid therapy
Abatacept
guidelines for drug use
BELATACEPT
belatacept
immunosuppressive agents
drug therapy, combination
recombinant fusion proteins
graft rejection
adult
kidney transplantation
infusions, intravenous
treatment outcome
clinical trials as topic

---
http://www.has-sante.fr/portail/jcms/c_1769785/fr/nulojix-belatacept-immunosuppresseur
2014
false
France
French
evaluation of the transparency committee
corticosteroid therapy
Abatacept
Abatacept
BELATACEPT
belatacept
immunosuppressive agents
drug therapy, combination
recombinant fusion proteins
graft rejection
adult
kidney transplantation
infusions, intravenous
treatment outcome
BELATACEPT
immunosuppressive agents
recombinant fusion proteins
clinical trials as topic

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69597619
2012
France
summary of product characteristics
BELATACEPT
nulojix
powders

---
http://www.has-sante.fr/portail/jcms/c_1230775/nulojix-belatacept-immunosuppresseur-synthese-d-avis
http://www.has-sante.fr/portail/jcms/c_1230756/nulojix-30112011synthese-ct11464
http://www.has-sante.fr/portail/jcms/c_1173171/nulojix-30-11-2011-avis-ct11464
2011
false
France
French
guidelines for drug use
evaluation of the transparency committee
corticosteroid therapy
Abatacept
Abatacept
BELATACEPT
BELATACEPT
drug therapy, combination
belatacept
kidney transplantation
graft rejection
immunosuppressive agents
immunosuppressive agents
adult
treatment outcome
infusions, intravenous
clinical trials, phase iii as topic
clinical trials, phase ii as topic

---
https://www.ema.europa.eu/medicines/human/EPAR/Nulojix
2011
false
United Kingdom
French
English
summary of product characteristics
package leaflet
drug evaluation
syndication feed
Abatacept
Abatacept
BELATACEPT
BELATACEPT
drug therapy, combination
belatacept
immunosuppressive agents
immunosuppressive agents
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
drug approval
treatment outcome
adult
graft rejection
kidney transplantation
infusions, intravenous

---